AlloVir Total Current Liabilities 2011-2026 | ALVR

Annual Total Current Liabilities AlloVir

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.71 M	24.7 M	28.4 M	24.3 M	37.9 M	12.3 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
37.9 M	9.71 M	22.9 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Rezolute RZLT	11.9 M	$ 3.37	5.82 %	$ 256 M	USA
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	5.75 M	-	10.36 %	$ 9.8 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Cabaletta Bio CABA	50.2 M	$ 2.85	2.34 %	$ 286 M	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Sana Biotechnology SANA	78.7 M	$ 3.13	0.97 %	$ 793 M	USA
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Equillium EQ	2.93 M	$ 2.11	2.43 %	$ 121 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	60.7 M	$ 1.34	0.75 %	$ 342 M	Britain
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	200 M	-	-	$ 546 M	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	70.6 M	-	-	$ 789 M	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	149 M	$ 48.18	2.32 %	$ 4.33 B	Schweiz
Arbutus Biopharma Corporation ABUS	6.01 M	$ 4.49	-0.99 %	$ 860 M	Canada
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Lixte Biotechnology Holdings LIXT	314 K	$ 2.86	-4.34 %	$ 5.48 M	USA
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA
Seer SEER	13.2 M	$ 1.72	-0.29 %	$ 110 M	USA
Brickell Biotech BBI	1.66 M	-	-5.38 %	$ 6.06 M	USA
Eli Lilly and Company LLY	35.2 B	$ 905.44	-1.19 %	$ 812 B	USA
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	14 M	-	-10.95 %	$ 876 K	USA